Study on the preparation of paclitaxel freeze-dried product for injection using hyaluronan as the base

Chinese Pharmaceutical Journal

Volumn 39, Issue 11, 2004, Pages 839-841

  Yin, Dian Shu ^a   Jiang, Jian Lan ^a   Yuan, Ying Jin ^a  

^a TIANJIN UNIVERSITY   (China)

Author keywords

Freeze drying; Hyaluronan; Paclitaxel; Preparation

Indexed keywords

CELLS; CYTOLOGY; DRYING; FREEZING; ONCOLOGY; PHARMACODYNAMICS; POLYSACCHARIDES; TOXICITY; TUMORS;

ANTITUMOR EFFECTS; INCREASED LIFE SPAN (ILS); PACLITAXEL; TUMOR GROWTH;

DRUG PRODUCTS;

HYALURONIC ACID; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; ENVIRONMENTAL TEMPERATURE; FREEZE DRYING; HUMAN; HUMAN CELL; IN VIVO STUDY; INJECTION; LIFESPAN; SIDE EFFECT; TECHNOLOGY; THERMOSTABILITY;

EID: 13144307075     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Lee JY, Spicer AP. Hyaluronan: a multifunctional, megaDlton, stealth molecule[J]. Curr Opinion Cell Biol, 2000, 12: 581.
2. Herrera-Gayol A, Jothy S. Effect of hyaluronan on xenotransplanted breast cancer [J]. Exp Mol Pathol, 2002, 72: 179.
3. Zeng CX, Toole BP, Kinney SD, et al. Inhibition of tumor growth in vivo by hyaluronan oligomers [J]. Int J Cancer, 1998, 77: 396.
4. Jackson JK, Skinner KC, Burgess L, et al. Paclitaxel-loaded Cross-linked Hyaluronic acid films for the prevention of postsurgical adhesions[J]. Pharm Research, 2002, 19: 411.
5. Brown TJ, Hatherell EM, Falzon J, et al. Hyaluronan as a drug delivery vehicle in breast cancer. Hyaluronan 2000 [C]. Wrexham, UK: The North East Wales Institute,2000: 32-34.